Skip to main content
AVTX logo

AVTX · Avalo Therapeutics, Inc. · Holdings

Track AVTX — free
$11.27 -0.74 (-6.16%) At close · Oct 16
Market Cap
$612.72M
Shares
53.63M
Volume · Oct 16 971.12K Avg daily vol (3M) 937.19K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 131
Total Value: $1,324,314,233
Total Shares: 71,662,080
Showing 1–100 of 137 holdings by value · page 1 of 2

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 127 13F filers
Top Holder
7.1%
Sep 2023 → Jun 2026 · range 6.6% – 70.7%
of institutional value
Top 5
26.9%
Sep 2023 → Jun 2026 · range 26.9% – 99.9%
of institutional value
Top 10
45.0%
Sep 2023 → Jun 2026 · range 44.6% – 100.0%
of institutional value
HHI
301
Sep 2023 → Jun 2026 · range 300 – 5,487
Broadly held
Showing 100 of 137
Export CSV
Holder Value (USD) % of 13F Shares Open

Showing the top 100 of 137 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1534120 CUSIP 05338F306 13F (30d) 8 filings 8 filers Visit website Investor relations